It started with a boxplot I couldn't explain.
My first encounter with clinical data was as a student assistant at the Institute for Medical Statistics in Düsseldorf — tasked with visualizing measurements from a dental implant study using SAS. I produced the plot. It was technically correct. And it made no sense whatsoever.
My supervisor told me as much. So I sat down, studied the variables, understood how they were collected and what they actually measured. Only then could I show something meaningful. That moment planted a seed I didn't recognize at the time: data without understanding is just noise dressed up as output.
Years later, the seed became a conviction. I was interviewing for my first move from CRO work into pharma. The Head of R&D asked what the clinical rationale was for the studies I'd worked on. I had nothing. I had processed the data. I had never read the protocol.
I left that interview deeply dissatisfied — not with them, but with myself. So I went home and read every protocol I could find. I spent the next year closing the gap — deliberately, methodically. When I finally made the move to Schwarz Pharma, it was because I felt ready. On my own terms.
That question followed me from Düsseldorf over Monheim to Wuppertal, from CRO to Schwarz Pharma to UCB to Bayer. It's the reason I believe statistical programming is not a support function, but the intelligence layer of drug development.
What is Clinical Trial Programming?
A clinical trial is a rigorously controlled scientific study that tests whether a new drug, treatment, or intervention is safe and effective in human patients — before it is approved for widespread use. Every approved medicine you or your family has taken went through this process.
Clinical trials generate enormous volumes of structured data: patient demographics, dosing records, laboratory measurements, safety events, efficacy outcomes. This data must be captured, standardized, validated, and transformed into formats that regulatory agencies — the FDA, EMA, and others — can review and rely upon to make approval decisions that affect millions of people.
Statistical programming is the discipline that does this work: transforming raw clinical data into analysis-ready datasets and the tables, listings, and figures that populate a regulatory submission. It sits at the intersection of data science, medical knowledge, and regulatory precision — and a single error can delay or derail a drug that patients are waiting for.